Ergoteles’s Genpact G Stock Holding History

Ergoteles’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,601	Closed	-$1.56M	–	353
2023 Q2	$1.56M	Sell	41,601 -21,788	-34%	-$877K	0.08%	339
2023 Q1	$2.93M	Buy	+63,389	New	+$2.96M	0.11%	171
2022 Q4	–	Sell	-18,724	Closed	-$820K	–	1606
2022 Q3	$820K	Buy	+18,724	New	+$861K	0.03%	568

Other funds holding G

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Ergoteles's G Position: Q3 2023 in Review

Ergoteles sold out of Genpact (G) in Q3 2023, closing a stake of 41,601 shares — an estimated $1.56M sold.

Ergoteles first reported a position in G in Q3 2022 and held it in 3 quarters. The position peaked at $2.93M in Q1 2023. 333 funds tracked by Wall St. Rank hold G as of Q3 2023.

Ergoteles reported no remaining Genpact position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 41,601 Genpact shares in Q3 2023, an estimated $1.56M.
Ergoteles first reported a position in Genpact in Q3 2022 and held it in 3 quarters.
Ergoteles's Genpact position peaked at $2.93M in Q1 2023.
333 funds tracked by Wall St. Rank held Genpact as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.